Clinical Trial Update: Study of the Safety and Efficacy of Conivaptan (Vaprisol®) to Raise Serum Sodium Levels in Patients With Severe Traumatic Brain Injury [Phase 1]

View source ↗

Summary

Phase 1 trial assessing the safety and efficacy of conivaptan (Vaprisol) to raise serum sodium in patients with traumatic brain injury has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Traumatic Brain Injury

Drugs mentioned

• Vaprisol (Conivaptan)

Snippet

Sponsor: University of Washington | Conditions: Severe Traumatic Brain Injury | Phase 1 | Status: COMPLETED